Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2022

Aug 23, 2022

34395_dirs_2022-08-23_e02168d8-3d45-42a2-a129-e57727b64791.zip

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-22-05:00

Reporting Person: Butera Salvatore Thomas (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-22-05:00 Common Stock P 5000 $1.64 Acquired 160000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7000 Direct

Footnotes

F1: These shares of common stock are jointly owned by the reporting person and his spouse.